➔ Myriad RBM ➔ Rules-Based Medicine, a Q2 Solutions Company
Rules-Based Medicine (RBM), an IQVIA business (formerly a Q2 Solutions Company), is a CLIA-certified immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services. RBM’s internally developed and manufactured immunoassay kits based on multi-analyte profiling (MAP) and ultrasensitive Single-Molecule Array (SimoaTM) technology, provide reproducible and quantitative data for hundreds of human proteins.
Sr. Marketing Manager (2018-2023) | Creative Director (2005-2015)
I joined Rules-Based Medicine in 2018 as a Senior Marketing Manager, charged with managing day-to-day marketing initiatives while contributing to broader strategic direction. My longstanding relationship with the company and deep understanding of the immunoassay testing industry provided an opportunity, shaped by a career that had already spanned five spin-offs and three acquisitions connected to RBM. This unique perspective allowed me to approach marketing with a blend of creative leadership and strategic insight, ensuring that every campaign, initiative, and piece of content aligned with the company’s brand, competitive advantages, and market position. My role was both hands-on and collaborative, working closely with leadership, sales, and scientific teams to build marketing that was not only creative but grounded in deep industry expertise.
Branding & Creative Direction
B2B Global Marketing
Thought Leadership & Content Strategy
Cross-Functional Leadership
SEO & Digital Optimization
Web & UX Oversight
Success in the highly specialized immunoassay testing industry required a focused, results-driven marketing approach. Across all three Rules-Based Medicine (RBM) companies, my primary objective was to help the sales team generate Net New Business (NNB) through targeted marketing strategies. By leveraging enterprise marketing tools, data-driven insights, and strategic lead generation efforts, we consistently met or exceeded growth goals, achieving a year-over-year NNB increase of 7–10% and total revenue growth.
2022 – Net New Business
Achieved 9% increase of NNB YoY of total revenue in 2021.
2023 – Net New Business
Achieved 10% increase of NNB YoY of total revenue in 2022.
2024 – Net New Business
Achieved 10% increase of NNB YoY of total revenue in 2024.
Strengthened brand presence by maintaining consistency in messaging, design, and superior customer service, fostering trust and preference in the market. A key differentiator for RBM was our innovative approach and the scientific advantage of integrating the most advanced technology available, paired with unmatched quality in both products and customer service. This reputation for excellence set RBM apart and was a core component of brand messaging and marketing initiatives.
— Data Driven Results —
This data-driven, multi-channel approach ensured that RBM not only met revenue goals but also strengthened long-term customer relationships, reinforcing brand loyalty and repeat business opportunities.
Click to watch video
A collaborative project between Luminex Corporation and Myriad RBM highlighting the link between the two companies.
Click to watch video
Milieu Intérieur project takes an unprecedented look at the human immune system by examining the genetic and environmental factors contributing to the variability of immune responses. Myriad RBM has an ongoing partnership with Milieu Intérieur with projects using the TruCulture system and thought leadership speaking events around various projects related to immuno
RBM's partners at, The Institut Pasteur, demonstrated the indispensable benefits of TruCulture in The Milieu Intérieur (“Environment Within”) project. The Milieu Intérieur project is working to establish the determinants of a healthy immune response by identifying the genetic, epigenetic and environmental factors that contribute to the observed heterogeneity of immune responses. They have been speaking at several events related to these efforts utilizing TruCulture in there studies. This thought leadership has been important in branding and introducing the product and services relalated to RBM.
Copyright: Institut Pasteur
Click to watch video
A celebration of the the retirement to a founder of Rules-Based Medicine, Dr. Ralph McDade. The purpose was to highlight the extraordinary journey that lead him to an successful serial entrepreneurial career and to his retirement.
STORYTELLING | ANIMATION | VIDEO EDITING | AI TECHNOLOGIES
Click to watch video
TruCulture tubes are designed to capture immune cell activity at the time and place of sample collection, thereby minimizing the bias and variability introduced by sample shipping and manipulation. These revolutionary tubes consist of an integrated whole-blood collection and leukocyte culture system that is reliable, simple to use and does not require specialized laboratory equipment. This video shows the process of proper sample collection. It has been useful in training and promotion.
RBM used trade events to build and maintain a consistent presence. We grew awareness by positioning our brand at strategic events, putting us in front of other industry leaders. Through networking and thought leadership speaking engagements, we strengthened existing relationships while establishing new ones. Trade shows became a cornerstone of our marketing strategy, generating leads and reinforcing RBM’s position as an industry leader.
Web Generated Leads
Increased website generated leads (MQLs) by 12%.
Increased Click Through Rates
Boosted CTR strategic targeted advertising by 6% over 6 month period.
SEO Competitor Research
Drove a 25% increase in organic search traffic through SEO improvements within six months.
Marketing Qualified Leads
Increased website activity by 10% for unique visitors, pageviews, pages per session, and average visitor sessions.
— Data Driven Results —
— Improved conversion rates and streamlined lead qualification, reducing ad spend on remarketing while maximizing ROI on new business acquisition.
One of the most significant drivers of marketing success at RBM was the collaborative effort across departments. From the Chief Scientific Officer to the CFO, CEO, Sales Team, and CMO, cross-functional collaboration played a critical role in shaping effective marketing strategies. Sales, in particular, was a key partner helping drive decisions through valuable insights from customer interactions, which directly informed marketing campaigns.
This collective approach ensured that marketing efforts were deeply aligned with business goals and scientific advancements. Whether it was generating content for brochures, websites, white papers, technical notes, newsletters, or advertising, every piece was informed by input from experts across the company, reinforcing RBM’s leadership position in the market.
Understanding campaign goal, target audience, and competitive landscapes.
Data-driven strategies to build visibility, engagement, and conversions.
Crafting intuitive and visually compelling experiences.
Deploying campaigns with precision and performance optimization.
In an industry where trust and credibility are paramount, our marketing efforts extended beyond traditional advertising. By developing and launching new products informed by market research and scientific insights, RBM maintained a competitive edge. Our strategic alignment with other brands, SEO enhancements, and thought leadership efforts helped position the company as a preferred choice, contributing to its successful acquisition without disruption to our sales and marketing strategies.
Rules-Based Medicine Founded
Rules-Based Medicine Inc. (RBM) was founded in 1998. RBM is a biotechnology company that specializes in biomarker testing, assay development, and pharmaceutical services.
Acquired by Myriad Genetics
Myriad Genetics acquired RBM for $80 million, integrating it as Myriad RBM, Inc. Their tests use biomarker patterns to measure low levels of protein analytes in blood. This helps the medical community bring safe and effective drugs to market.
Acquired by IQVIA
IQVIA acquired Myriad RBM for $198 million, making it part of its Q² Solutions unit. These acquisitions reinforced RBM’s market leadership, technological edge, and reputation for excellence.